云南白药全资子公司拟收购聚药堂100%股权

Group 1 - The core point of the article is that Yunnan Baiyao announced the acquisition of 100% equity in An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for a total consideration of 660 million RMB [1] - The acquisition will be conducted by Yunnan Baiyao's wholly-owned subsidiary, Yunnan Baiyao Group Traditional Chinese Medicine Resources Co., Ltd. [1] - Ju Yao Tang specializes in the production and sales of traditional Chinese medicine pieces, toxic traditional Chinese medicine pieces, directly consumable traditional Chinese medicine pieces, and formula granules, demonstrating stable profitability [1]